Archetti, Damiano https://orcid.org/0000-0003-0818-7685
Ingala, Silvia
Venkatraghavan, Vikram
Wottschel, Viktor https://orcid.org/0000-0002-2902-2268
Young, Alexandra L.
Bellio, Maura
Bron, Esther E. https://orcid.org/0000-0002-5778-9263
Klein, Stefan https://orcid.org/0000-0003-4449-6784
Barkhof, Frederik
Alexander, Daniel C.
Oxtoby, Neil P. https://orcid.org/0000-0003-0203-3909
Frisoni, Giovanni B.
Redolfi, Alberto
Funding for this research was provided by:
Eli Lilly and Company
Horizon 2020 Framework Programme
Genentech
European Federation of Pharmaceutical Industries and Associations
Virginia Information Technologies Agency (283562)
University College London Hospitals NHS Foundation Trust
Alzheimer's Disease Neuroimaging Initiative
Innovative Medicines Initiative (115736)
Alzheimer's Association
BioClinica
UCLH Biomedical Research Centre
Alzheimer's Drug Discovery Foundation
Northern California Institute for Research and Education
U.S. Department of Defense (W81XWH-12-2-0012)
GE Healthcare
Horizon 2020 (634541)
Horizon 2020 (666992)
National Institute on Aging
F. Hoffmann-La Roche
National Institute of Biomedical Imaging and Bioengineering
Janssen Alzheimer Immunotherapy Research And Development
Biogen
National Institute for Health and Care Research
University of Southern California
European Commission (P01 AG03991)
European Commission (P50 AG05681)
European Commission (P50 MH071616)
European Commission (R01 AG021910)
European Commission (R01 MH56584)
European Commission (U24 RR021382)
National Institutes of Health (U01 AG024904)
AbbVie
Fujirebio Europe
This article is maintained by: Elsevier
Article Title: Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease
Journal Title: NeuroImage: Clinical
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nicl.2019.101954
Content Type: article
Copyright: © 2019 The Authors. Published by Elsevier Inc.